‘Conqueror’: Black Cleveland minister shares prostate cancer battle

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...
BMJ

Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study

Background Prostate cancer (PCa) is the most common male malignancy in the western world. Many men (40%) are diagnosed with localised low or intermediate-risk PCa, which is suitable for active ...
Cure Today

ASCO GU 2026 Day One Update: Advancements in Prostate Cancer Treatment

Yesterday marked day one of the 2026 ASCO Genitourinary (GU) Cancers Symposium, and the updates were full of hope for people with advanced prostate cancer. CURE highlights two studies that are ...
Cure Today

Truqap Plus Zytiga Maintains Quality of Life in PTEN-Deficient Prostate Cancer

A global phase 3 trial enrolled mHSPC with ≥90% PTEN loss by IHC and randomized 1,012 patients to intermittent capivasertib plus abiraterone/prednisone versus ...